Overview

Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to characterize the effects of a single-dose of retigabine on cortical excitability in healthy subjects, as quantified by means of TMS.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital of Mont-Godinne
Collaborators:
GlaxoSmithKline
Université Catholique de Louvain
Treatments:
Ezogabine